Literature DB >> 27583244

Retraction Note: therapeutic stimulation of GLP-1 and GIP protein with DPP-4 inhibitors for type-2 diabetes treatment.

Alok Sharma1, Geetanjali Paliwal1, Nisha Upadhyay1, Archana Tiwari1.   

Abstract

[This retracts the article DOI: 10.1186/s40200-015-0143-4.].

Entities:  

Year:  2016        PMID： 27583244      PMCID： PMC5006406          DOI： 10.1186/s40200-016-0256-4

Source DB:  PubMed          Journal:  J Diabetes Metab Disord        ISSN： 2251-6581


The Editors are retracting this article [1] due to overlap with previous publications, most notably [2, 3]. We apologise for any inconvenience caused. We have been unable to contact the authors regarding the retraction of their article.
  3 in total

Review 1.  Enhancing incretin action for the treatment of type 2 diabetes.

Authors:  Daniel J Drucker
Journal:  Diabetes Care       Date:  2003-10       Impact factor: 19.112

2.  Therapeutic stimulation of GLP-1 and GIP protein with DPP-4 inhibitors for type-2 diabetes treatment.

Authors:  Alok Sharma; Geetanjali Paliwal; Nisha Upadhyay; Archana Tiwari
Journal:  J Diabetes Metab Disord       Date:  2015-03-19

Review 3.  The dipeptidyl peptidase (DPP)-4 inhibitors for type 2 diabetes mellitus in challenging patient groups.

Authors:  David Kountz
Journal:  Adv Ther       Date:  2013-11-28       Impact factor: 3.845
  3 in total
  1 in total

Review 1.  Role of Dipeptidyl Peptidase 4 Inhibitors in Antidiabetic Treatment.

Authors:  Ruili Yin; Yongsong Xu; Xin Wang; Longyan Yang; Dong Zhao
Journal:  Molecules       Date:  2022-05-10       Impact factor: 4.927
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.